Characterization of Ectonucleotidases in Human Medulloblastoma Cell Lines: Ecto-5′NT/CD73 in Metastasis as Potential Prognostic Factor

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Cappellari, Angélica Regina ^a   Rockenbach, Liliana ^a   Dietrich, Fabrícia ^a   Clarimundo, Vanessa ^a   Glaser, Talita ^b   Braganhol, Elizandra ^c   Abujamra, Ana Lúcia ^d,e   Roesler, Rafael ^a,d   Ulrich, Henning ^b   liveira Battastini, Ana Maria ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e Instituto do Câncer Infantil do RS ICI RS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; BETA CATENIN; ECTO 5' NUCLEOTIDASE; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; INOSINE; PHOSPHATASE; PHOSPHODIESTERASE; PYROPHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CELL STRAIN D283; CELL STRAIN DAOY; CELL STRAIN ONS76; CELLULAR SECRETION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME REPRESSION; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOREACTIVITY; MEDULLOBLASTOMA; METASTASIS; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; TUMOR CELL LINE;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; BETA CATENIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CEREBELLUM; CHILD; DIPHOSPHATES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDULLOBLASTOMA; NEOPLASM METASTASIS; ORGAN SPECIFICITY; PHOSPHORIC DIESTER HYDROLASES; PROGNOSIS; PYROPHOSPHATASES; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84867638014     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047468     Document Type: Article

References (43)

1. Koeller KK, Rushing EJ, (2003) From the archives of the AFIP: medulloblastoma: a comprehensive review with radiologic-pathologic correlation. Radiographics 23: 1613-1637.
2. Muoio VM, Shinjo SO, Matushita H, Rosemberg S, Teixeira MJ, et al. (2011) Extraneural metastases in medulloblastoma. Arq Neuropsiquiatr 69: 328-331.
3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
4. Schmidt AL, Brunetto AL, Schwartsmann G, Roesler R, Abujamra AL, (2010) Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets. CNS Neurol Disord Drug Targets 9: 335-348.
5. Roussel MF, Robinson G, (2011) Medulloblastoma: advances and challenges. F1000 Biol Rep 3: 5.
6. Rodini CO, Suzuki DE, Nakahata AM, Pereira MC, Janjoppi L, et al. (2010) Aberrant signaling pathways in medulloblastomas: a stem cell connection. Arq Neuropsiquiatr 68: 947-952.
7. Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, et al. (2005) beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23: 7951-7957.
8. Spychala J, (2000) Tumor-promoting functions of adenosine. Pharmacol Ther 87: 161-173.
9. Bavaresco L, Bernardi A, Braganhol E, Cappellari AR, Rockenbach L, et al. (2008) The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation. Mol Cell Biochem 319: 61-68.
10. Stagg J, Smyth MJ, (2010) Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29: 5346-5358.
11. Stella J, Bavaresco L, Braganhol E, Rockenbach L, Farias PF, et al. (2009) Differential ectonucleotidase expression in human bladder cancer cell lines. Urol Oncol 28: 260-267.
12. Fields RD, Burnstock G, (2006) Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 7: 423-436.
13. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H, (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32: 19-29.
14. Robson SC, Sevigny J, Zimmermann H, (2006) The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2: 409-430.
15. Zimmermann H, (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362: 299-309.
16. Zimmermann H, Zebisch M, Strater N, (2012) Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8: 437-502.
17. Strater N, (2006) Ecto-5′-nucleotidase: Structure function relationships. Purinergic Signal 2: 343-350.
18. Yegutkin GG, (2008) Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783: 673-694.
19. Millan JL, (2006) Alkaline Phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal 2: 335-341.
20. Ohkubo S, Kimura J, Matsuoka I, (2000) Ecto-alkaline phosphatase in NG108-15 cells: a key enzyme mediating P1 antagonist-sensitive ATP response. Br J Pharmacol 131: 1667-1672.
21. Picher M, Burch LH, Hirsh AJ, Spychala J, Boucher RC, (2003) Ecto 5′-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278: 13468-13479.
22. Franco R, Casado V, Ciruela F, Saura C, Mallol J, et al. (1997) Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 52: 283-294.
23. Wink MR, Lenz G, Braganhol E, Tamajusuku AS, Schwartsmann G, et al. (2003) Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Lett 198: 211-218.
24. Morrone FB, Horn AP, Stella J, Spiller F, Sarkis JJ, et al. (2005) Increased resistance of glioma cell lines to extracellular ATP cytotoxicity. J Neurooncol 71: 135-140.
25. Wink MR, Braganhol E, Tamajusuku AS, Casali EA, Karl J, et al. (2003) Extracellular adenine nucleotides metabolism in astrocyte cultures from different brain regions. Neurochem Int 43: 621-628.
26. Morrone FB, Jacques-Silva MC, Horn AP, Bernardi A, Schwartsmann G, et al. (2003) Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines. J Neurooncol 64: 211-218.
27. Castellino RC, De Bortoli M, Lin LL, Skapura DG, Rajan JA, et al. (2007) Overexpressed TP73 induces apoptosis in medulloblastoma. BMC Cancer 7: 127.
28. Khaw AK, Silasudjana M, Banerjee B, Suzuki M, Baskar R, et al. (2007) Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. Mutat Res 625: 134-144.
29. Belcher SM, Ma X, Le HH, (2009) Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma. Endocrinology 150: 1112-1121.
30. von Bueren AO, Shalaby T, Oehler-Janne C, Arnold L, Stearns D, et al. (2009) RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer 9: 10.
31. Sakura H, Nagashima S, Nakashima A, Maeda M, (1998) Characterization of fetal serum 5′-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation. Thromb Res 91: 83-89.
32. Chan KM, Delfert D, Junger KD, (1986) A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem 157: 375-380.
33. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
34. Stefan C, Jansen S, Bollen M, (2006) Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signal 2: 361-370.
35. Goding JW, Grobben B, Slegers H, (2003) Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta 1638: 1-19.
36. Braganhol E, Tamajusuku AS, Bernardi A, Wink MR, Battastini AM, (2007) Ecto-5′-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line. Biochim Biophys Acta 1770: 1352-1359.
37. Villar J, Arenas MI, MacCarthy CM, Blanquez MJ, Tirado OM, et al. (2007) PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism. Cancer Res 67: 10859-10868.
38. Aerts I, Martin JJ, De Deyn PP, Van Ginniken C, Van Ostade X, et al. (2011) The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade. Clin Neurol Neurosurg 113: 224-229.
39. Grobben B, Anciaux K, Roymans D, Stefan C, Bollen M, et al. (1999) An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J Neurochem 72: 826-834.
40. Stefan C, Jansen S, Bollen M, (2005) NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 30: 542-550.
41. Gilbertson RJ, Ellison DW, (2008) The origins of medulloblastoma subtypes. Annu Rev Pathol 3: 341-365.
42. Polakis P, (2000) Wnt signaling and cancer. Genes Dev 14: 1837-1851.
43. Spychala J, Kitajewski J, (2004) Wnt and beta-catenin signaling target the expression of ecto-5′-nucleotidase and increase extracellular adenosine generation. Exp Cell Res 296: 99-108.